Sagimet Biosciences Inc. (SGMT) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Sagimet Biosciences Inc. (SGMT) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

SGMT Income Statement

Sagimet Biosciences Inc. (SGMT) annual income statement — 7-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22

Sales/Revenue	0	0	0	0	0	0	0	0	0	0	0	2M	0	0	0
Revenue Growth %	-	-	-	-	-	-	-	-100%	-	-	-	-	-	-	-
Cost of Goods Sold	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0	0	2M	0	0	0
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	100%	-	-	-
Gross Profit Growth %	-	-	-	-	-	-	-	-100%	-	-	-	-	-	-	-
Operating Expenses	15.82M	11.71M	10.77M	14.33M	11.93M	19.86M	18.2M	16.9M	10.59M	8.77M	9.47M	9.45M	7.06M	6.76M	7.39M
OpEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	472.6%	-	-	-
Selling, General & Admin	4.28M	4.72M	4.03M	4.6M	4.68M	4.52M	3.98M	4.25M	4.28M	3.51M	3.81M	4.49M	2.38M	2.28M	1.54M
SG&A % of Revenue	-	-	-	-	-	-	-	-	-	-	-	224.7%	-	-	-
Research & Development	11.54M	7M	6.73M	9.73M	7.25M	15.34M	14.22M	12.65M	6.31M	5.26M	5.66M	4.96M	4.68M	4.49M	5.85M
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-	-	247.9%	-	-	-
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Income	-15.82M	-11.71M	-10.77M	-14.33M	-11.93M	-19.86M	-18.2M	-16.9M	-10.59M	-8.77M	-9.47M	-7.45M	-7.06M	-6.76M	-7.39M
Operating Margin %	-	-	-	-	-	-	-	-	-	-	-	-372.6%	-	-	-
Operating Income Growth %	-32.65%	41.04%	40.84%	15.19%	-12.62%	-126.56%	-92.21%	-126.81%	-50.05%	-29.61%	-28.13%	-	-	-	-
EBITDA	-13.95M	-10.65M	-12.19M	-12.91M	-10.39M	-18.18M	-16.2M	-14.62M	-8.12M	0	0	-7.45M	-7.06M	-6.76M	0
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-	-	-372.6%	-	-	-
EBITDA Growth %	-34.34%	41.41%	24.75%	11.7%	-27.94%	-	-	-96.18%	-15.03%	100%	-	-	-	-	-
D&A (Non-Cash Add-back)	0	0	0	0	0	0	0	0	0	8.77M	9.47M	0	0	0	7.39M
EBIT	-13.95M	-10.65M	-12.19M	-12.91M	-10.39M	-18.18M	-16.2M	-14.62M	-8.12M	-6.63M	-9.47M	-7.45M	-7.06M	-6.76M	-7.39M
Net Interest Income	0	1.06M	-3.23M	1.43M	1.54M	1.69M	1.99M	2.28M	2.47M	2.14M	1.31M	1.09M	272K	180K	193K
Interest Income	0	1.06M	-3.23M	1.43M	1.54M	1.69M	1.99M	2.28M	2.47M	2.14M	1.31M	1.09M	271K	180K	193K
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	1.86M	1.06M	1.2M	1.43M	1.54M	1.69M	1.99M	2.28M	2.47M	2.14M	1.31M	1.1M	272K	178K	193K
Pretax Income	-13.95M	-10.65M	-9.57M	-12.91M	-10.39M	-18.18M	-16.2M	-14.62M	-8.12M	-6.63M	-8.15M	-6.35M	-6.79M	-6.59M	-7.2M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-	-	-317.65%	-	-	-
Income Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	-13.95M	-10.65M	-9.57M	-12.91M	-10.39M	-18.18M	-16.2M	-14.62M	-8.12M	-6.63M	-8.15M	-6.35M	-6.79M	-6.59M	-7.2M
Net Margin %	-	-	-	-	-	-	-	-	-	-	-	-317.65%	-	-	-
Net Income Growth %	-34.34%	41.41%	40.94%	11.7%	-27.94%	-174.19%	-98.76%	-130.11%	-19.65%	-0.64%	-13.29%	-	-	-	-
Net Income (Continuing)	-13.95M	-10.65M	-9.57M	-12.91M	-10.39M	-18.18M	-16.2M	-14.62M	-8.12M	-6.63M	-8.15M	-6.35M	-6.79M	-6.59M	-7.2M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.26	-0.33	-0.29	-0.40	-0.32	-0.56	-0.50	-0.45	-0.25	-0.23	-0.45	-0.35	-0.31	-0.30	-0.32
EPS Growth %	18.75%	41.07%	42%	11.11%	-28%	-143.48%	-11.11%	-28.57%	19.35%	23.33%	-40.63%	-	-	-	-
EPS (Basic)	-0.26	-0.33	-0.29	-0.40	-0.32	-0.56	-0.50	-0.45	-0.25	-0.23	-0.45	-0.35	-0.31	-0.30	-0.32
Diluted Shares Outstanding	53.11M	32.56M	32.52M	32.46M	32.2M	32.2M	32.2M	32.14M	31.91M	29.04M	18.19M	18.19M	22.17M	22.17M	22.17M
Basic Shares Outstanding	53.11M	32.56M	32.52M	32.46M	32.2M	32.2M	32.2M	32.14M	31.91M	29.04M	18.19M	18.19M	22.17M	22.17M	22.17M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-